MIPLYFFA Shows 5-Year Disease Stability in Niemann-Pick Type C Treatment Study
Zevra Therapeutics (NASDAQ:ZVRA) announced the presentation of four posters at…
ZVRA Showcases Key Findings on MIPLYFFA and OLPRUVA at Genetics
Zevra Therapeutics (ZVRA, Financial) is presenting significant research on its treatments, MIPLYFFA and OLPRUVA, at the 42nd Annual…